{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T18:45:26Z","timestamp":1768589126638,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005521","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T00:00:00Z","timestamp":1208908800000}}],"reference-count":50,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005521.pub2","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T09:56:47Z","timestamp":1208771807000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Systemic corticosteroids for acute gout"],"prefix":"10.1002","volume":"2010","author":[{"given":"Hein J","family":"Janssens","sequence":"first","affiliation":[{"name":"Transeedijk 62 Lobith Netherlands 6915 XZ"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter LBJ","family":"Lucassen","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre; Department of General Practice and Family Medicine; 117 Hag PO Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floris A","family":"Van de Laar","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Centre; Department of General Practice, 117 HAG; P.O. Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"Janssen","sequence":"additional","affiliation":[{"name":"Rijnstate Hospital Arnhem; Rheumatology; PO Box 9555 Arnhem Netherlands 6800 TA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloy H","family":"Van de Lisdonk","sequence":"additional","affiliation":[{"name":"Radboud University Medical Centre Nijmegen; Department of General Practice and Family Medicine, 117 HAG; PO Box 9101 Nijmegen Netherlands 6500 HB"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,4,23]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD005521.pub2-BIB0001|cit1","first-page":"111","article-title":"Comparison of triamcinolone acetonide with indomethacin in the treatment of acute gouty arthritis","volume":"20","author":"Alloway","year":"1993","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.annemergmed.2006.11.014","article-title":"Comparison of oral prednisolone\/paracetamol and oral indomethacin\/paracetamol combination therapy in the treatment of acute goutlike arthritis: a double-blind, randomized, controlled trial","volume":"49","author":"Man","year":"2007","journal-title":"Annals of Emergency Medicine"},{"issue":"7","key":"10.1002\/14651858.CD005521.pub2-BIB0003|cit3","first-page":"1325","article-title":"Comparison of adrenocorticotropic hormone and triamcinolone acetonide in the treatment of acute gouty arthritis","volume":"21","author":"Siegel","year":"1994","journal-title":"The Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD005521.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/art.1780310618","article-title":"Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout","volume":"31","author":"Axelrod","year":"1988","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD005521.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2165\/00002018-199411040-00004","article-title":"Risks and benefits of drugs used in the management and prevention of gout","volume":"11","author":"Conaghan","year":"1994","journal-title":"Drug Safety: an international journal of medical toxicology and drug experience"},{"issue":"6","key":"10.1002\/14651858.CD005521.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0049-0172(90)90070-V","article-title":"Systemic steroid therapy for acute gout: a clinical trial and review of the literature","volume":"19","author":"Groff","year":"1990","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"4","key":"10.1002\/14651858.CD005521.pub2-BIB0007|cit7","first-page":"248","article-title":"Corticosteroid therapy for the treatment of acute attacks of crystal-induced arthritis: an effective alternative to nonsteroidal antiinflammatory drugs","volume":"63","author":"Werlen","year":"1996","journal-title":"Revue du rhumatisme (English edition )"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0008|cit8","unstructured":"Van de Lisdonk E Randomised double blind trial of prednisone and naproxen in treatment of crystal proven acute gout http:\/\/www.controlled-trials.com\/ISRCTN14648181\/14648181 2005"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0895-4356(88)90127-8","article-title":"Gout and coronary heart disease: the Framingham Study","volume":"41","author":"Abbott","year":"1988","journal-title":"Journal of Clinical Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD005521.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1445-5994.1987.tb01232.x","article-title":"Does colchicine work? The results of the first controlled study in acute gout","volume":"17","author":"Ahern","year":"1987","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0011|cit11","first-page":"1422","article-title":"Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study","volume":"15","author":"Altman","year":"1988","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2125.1988.tb03412.x","article-title":"Comparison of the natural history of untreated acute gouty arthritis vs acute arthritis treated with non-steroidal-anti-inflammatory drugs","volume":"26","author":"Arnold","year":"1988","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"11","key":"10.1002\/14651858.CD005521.pub2-BIB0013|cit13","first-page":"2403","article-title":"Epidemiology of gout: is the incidence rising?","volume":"29","author":"Arromdee","year":"2002","journal-title":"The Journal of Rheumatology"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2125.1987.tb03132.x","article-title":"Observations on spontaneous improvement in patients with podagra: implications for therapeutic trials of non-steroidal anti-inflammatory drugs","volume":"24","author":"Bellamy","year":"1987","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"8","key":"10.1002\/14651858.CD005521.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1002\/art.20438","article-title":"Gout: on the brink of novel therapeutic options for an ancient disease","volume":"50","author":"Bieber","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0016|cit16","unstructured":"Chris Cates www.nntonline.com Visual Rx - NNT Calculator 2003"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/001316446002000104","article-title":"A coefficient of agreement for nominal scales","volume":"20","author":"Cohen","year":"1960","journal-title":"Educational and Psychological Measurement"},{"issue":"3","key":"10.1002\/14651858.CD005521.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00002512-199813030-00006","article-title":"Gout in the elderly. Clinical presentation and treatment","volume":"13","author":"Fam","year":"1998","journal-title":"Drugs & Aging"},{"issue":"1","key":"10.1002\/14651858.CD005521.pub2-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000189.pub2","article-title":"Short-term low-dose corticosteroids vs placebo and nonsteroidal anti-inflammatory drugs in rheumatoid arthritis","author":"Gotzsche","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD005521.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0021|cit21","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] www.cochrane.org\/resources\/handbook\/hbook.htm"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/fampra\/cmg413","article-title":"Gout, just a nasty event or a cardiovascular signal? A study from primary care","volume":"20","author":"Janssens","year":"2003","journal-title":"Family Practice"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/ard.2005.040360","article-title":"Gout, not induced by diuretics? A case-control study from primary care","volume":"65","author":"Janssens","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/bmj.313.7048.36","article-title":"Trials to assess equivalence: the importance of rigorous methods","volume":"313","author":"Jones","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1002\/14651858.CD005521.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0149-2918(03)80158-3","article-title":"A literature review of the epidemiology and treatment of acute gout","volume":"25","author":"Kim","year":"2003","journal-title":"Clinical Therapeutics"},{"issue":"8","key":"10.1002\/14651858.CD005521.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1002\/art.22014","article-title":"Gout and the risk of acute myocardial infarction","volume":"54","author":"Krishnan","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1046\/j.1365-2125.2002.01636.x","article-title":"Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data","volume":"54","author":"Lewis","year":"2002","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"7","key":"10.1002\/14651858.CD005521.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1185\/03007999109111513","article-title":"Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout","volume":"12","author":"Maccagno","year":"1991","journal-title":"Current Medical Research and Opinion"},{"issue":"7426","key":"10.1002\/14651858.CD005521.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1136\/bmj.327.7426.1275","article-title":"Colchicine in acute gout","volume":"327","author":"Morris","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD005521.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000045783","article-title":"Improvement of renal function in patients with chronic gout after proper control of hyperuricemia and gouty bouts","volume":"86","author":"Perez-Ruiz","year":"2000","journal-title":"Nephron"},{"issue":"7","key":"10.1002\/14651858.CD005521.pub2-BIB0032|cit32","first-page":"1566","article-title":"Treatment of acute gout in hospitalized patients","volume":"34","author":"Petersel","year":"2007","journal-title":"The Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD005521.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ije\/31.1.150","article-title":"Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed","volume":"31","author":"Robinson","year":"2002","journal-title":"International Journal of Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD005521.pub2-BIB0034|cit34","article-title":"Early emergency department treatment of acute asthma with systemic corticosteroids","author":"Rowe","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005521.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/art.20007","article-title":"Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial","volume":"50","author":"Rubin","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"21","key":"10.1002\/14651858.CD005521.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.2165\/00003495-200464210-00003","article-title":"Management of acute and chronic gouty arthritis: present state-of-the-art","volume":"64","author":"Schlesinger","year":"2004","journal-title":"Drugs"},{"issue":"4","key":"10.1002\/14651858.CD005521.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006190","article-title":"Colchicine for acute gout","author":"Schlesinger","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2A","key":"10.1002\/14651858.CD005521.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"46S","DOI":"10.1016\/S0002-9343(97)89546-0","article-title":"Crystal-induced arthritis: an overview","volume":"100","author":"Schumacher","year":"1996","journal-title":"The American Journal of Medicine"},{"issue":"7352","key":"10.1002\/14651858.CD005521.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1136\/bmj.324.7352.1488","article-title":"Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis","volume":"324","author":"Schumacher","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0040|cit40","first-page":"2452","article-title":"Outcome measures for acute and chronic gout","volume":"32","author":"Schumacher","year":"2005","journal-title":"The Journal of Rheumatology"},{"issue":"6","key":"10.1002\/14651858.CD005521.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0196-0644(95)70037-4","article-title":"Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis","volume":"26","author":"Shrestha","year":"1995","journal-title":"Annals of Emergency Medicine"},{"issue":"1","key":"10.1002\/14651858.CD005521.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/ard.36.1.80","article-title":"Multicentre trial of naproxen and phenylbutazone in acute gout","volume":"36","author":"Sturge","year":"1977","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1093\/rheumatology\/kel071","article-title":"Effectiveness of interventions for the treatment of acute and prevention of recurrent gout - a systematic review","volume":"45","author":"Sutaria","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"17","key":"10.1002\/14651858.CD005521.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Clinical practice. Gout","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0045|cit45","volume-title":"Evidence Based Rheumatology","author":"Tugwell","year":"2004"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bmj.332.7553.1315","article-title":"Diagnosis and management of gout","volume":"332","author":"Underwood","year":"2006","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0047|cit47","article-title":"Diseases in general practice","volume-title":"Ziekten in de Huisartspraktijk","author":"Lisdonk","year":"2003"},{"key":"10.1002\/14651858.CD005521.pub2-BIB0048|cit48","unstructured":"Van der Linden MW Wetsert GP De Bakker DH Schellevis FG Illness and disease in the community and family practice Tweede Nationale Studie naar ziekten en verrichtingen in de huisartspraktijk Utrecht, Bilthoven NIVEL, Rijksinstituut voor Volksgezondheid en Milieu http:\/\/www.nivel.nl\/pdf\/ns2_rapport1.pdf"},{"issue":"3","key":"10.1002\/14651858.CD005521.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD005521.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00002281-199605000-00014","article-title":"Gouty arthritis and uric acid metabolism","volume":"8","author":"Wise","year":"1996","journal-title":"Current Opinion in Rheumatology"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD005521.pub2\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T10:03:46Z","timestamp":1626170626000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005521.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Musculoskeletal Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2008,4,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005521.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,23]]}}}